ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31
|
|
|
- Bernice Gallagher
- 5 years ago
- Views:
Transcription
1 R=Rare Tier Tumour ICD-O Topography code ICD-O Morphology code EPITHELIAL TUMOURS OF NASAL CAVITY AND SINUSES R 2 Squamous cell carcinoma with variants of nasal cavity and sinuses C30.0, C3 C30.0, C3 8000, 800, 8004, 800, 80, , 8032, , 8078, , 823, 844, 8560, , 8032, , 8078, , 823, 8560, Squamous carcinoma C30.0, C Verrucous carcinoma C30.0, C Squamous cell carcinoma spindle cell C30.0, C3 8004, 8032, 8074, Papillary squamous cell carcinoma C30.0, C Adenosquamous carcinoma C30.0, C Squamous cell carcinoma, adenoid C30.0, C Basaloid squamous cell carcinoma C30.0, C R 2 Lymphoepithelial carcinoma of nasal cavity and sinuses R 2 Undifferentiated carcinoma of nasal cavity and sinuses R 2 Intestinal type adenocarcinoma of nasal cavity and sinuses C30.0, C3 C30.0, C3 C30.0, C EPITHELIAL TUMOURS OF NASOPHARYNX C , 8004, , , 8032, , 8078, , 823, 8260, 8560, 8980 R 2 Squamous cell carcinoma with variants of nasopharynx C 8004, , 8032, , 8078, , 823, 8560, Squamous carcinoma C Squamous cell carcinoma nonkeratinizing, NOS C Squamous cell carcinoma keratinizing, NOS C Papillary squamous cell carcinoma C Basaloid squamous cell carcinoma C 8083
2 3 Squamous cell carcinoma, adenoid C Lymphoepithelial carcinoma C Undifferentiated carcinoma C R 2 Papillary adenocarcinoma of nasopharynx C 8050, 8260 EPITHELIAL TUMOURS OF MAJOR SALIVARY GLANDS AND SALIVARY-GLAND TYPE TUMOURS R 2 Epithelial tumours of major salivary glands C7, C8 3 Squamous carcinoma C7, C8 C00-C4, C30.0, C3, C32 (For C00-C4, C30.0, C3, C32) 840, 847, 8200, 8290, 830, 8430, 8440, 8450, , 8500, 8525, 8550, 8562, 894, 8982; (For C7, C8) 8004, 802, , 8032, , 8082, 82, 8230, 8255, 8260, 8262, 8290, 830, 8320, 8323, 840, 8940, , 802, , 8032, , 8082, 840, 847, 8200, 82, 8230, 8255, 8260, 8262, 8290, 830, 8320, 8323, 840, 8430, 8440, 8450, , 8500, 8525, 8550, 8562, 8940, 894, 8980, Large cell carcinoma C7, C Lymphoepithelial carcinoma C7, C Carcinosarcoma, NOS C7, C8 8004, 8032, 8074, Adenocarcinoma NOS C7, C Clear cell adenocarcinoma, NOS C7, C Mucinous adenocarcinoma C7, C Ductal carcinoma C7, C Oxyphilic adenocarcinoma C7, C Papillary cystadenocarcinoma, NOS C7, C Adenoid cystic carcinoma C7, C Mucoepidermoid carcinoma C7, C Acinar cell adenocarcinoma C7, C8 8550
3 3 Malignant myoepithelioma C7, C Carcinoma in pleomorphic adenoma C7, C Mixed tumour, malignant C7, C Polymorphous low grade adenocarcinoma C7, C Basal cell adenocarcinoma C7, C Epithelial-myoepithelial carcinoma C7, C Sebaceous adenocarcinoma C7, C Cystadenocarcinoma, NOS C7, C Low grade cribriform cystadenocarcinoma C7, C8 malignancy without ICD-O morphology code R 2 Salivary gland type tumours of head and neck C00-C06, C09-C4, C30.0, C3, C32 3 Mucoepidermoid carcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Adenocarcinoma NOS C00-C06, C09-C4, C30.0, C3, C32 3 Adenoid cystic carcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Acinar cell adenocarcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Ductal carcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Mucinous adenocarcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Basal cell adenocarcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Clear cell adenocarcinoma, NOS C00-C06, C09-C4, C30.0, C3, C32 3 Epithelial-myoepithelial carcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Polymorphous low grade adenocarcinoma C00-C06, C09-C4, C30.0, C3, C32 840, 847, 8200, 8290, 830, 8430, 8440, 8450, , 8500, 8525, 8550, 8562, 894,
4 3 Carcinoma in pleomorphic adenoma C00-C06, C09-C4, C30.0, C3, C32 3 Malignant myoepithelioma C00-C06, C09-C4, C30.0, C3, C32 3 Cystadenocarcinoma, NOS C00-C06, C09-C4, C30.0, C3, C32 3 Oncocytic carcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Papillary cystadenocarcinoma, NOS C00-C06, C09-C4, C30.0, C3, C EPITHELIAL TUMOURS OF HYPOPHARYNX AND LARYNX R 2 Squamous cell carcinoma with variants of hypopharynx C2, C3, C32 C2, C , 8004, , , , , 8078, , 823, 8560, , , , , 8078, , 823, 8560, Squamous carcinoma C2, C Lymphoepithelial carcinoma C2, C Verrucous carcinoma C2, C Squamous cell carcinoma spindle cell C2, C3 8004, 8032, 8074, Giant cell carcinoma C2, C Adenosquamous carcinoma C2, C Squamous cell carcinoma, adenoid C2, C Undifferentiated carcinoma C2, C Papillary squamous cell carcinoma C2, C Basaloid squamous cell carcinoma C2, C R 2 Squamous cell carcinoma with variants of larynx C , , , , 8078, , 823, 8560, Squamous carcinoma C Verrucous carcinoma C32 805
5 3 Squamous cell carcinoma spindle cell C , 8074, 8032, Papillary squamous cell carcinoma C Adenosquamous carcinoma C Squamous cell carcinoma, adenoid C Undifferentiated carcinoma C Lymphoepithelial carcinoma C Giant cell carcinoma C Basaloid squamous cell carcinoma C EPITHELIAL TUMOURS OF OROPHARYNX C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C , C4.2 R 2 Squamous cell carcinoma with variants of oropharynx C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C , C4.2 3 Squamous carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C , C4.2 3 Lymphoepithelial carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C , C4.2 3 Verrucous carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C , C4.2 3 Squamous cell carcinoma spindle cell C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C , C4.2 3 Papillary squamous cell carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C , C4.2 3 Squamous cell carcinoma, adenoid C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C , C4.2 3 Basaloid squamous cell carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C , C4.2 3 Adenosquamous carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C , C4.2 3 Undifferentiated carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C , C4.2 EPITHELIAL TUMOURS OF ORAL CAVITY AND LIP C00.0-C00.9 C02.0-C02.3, C02.9, C03.0-C05.0, C06.0- C , 8004, , , 8032, , 8078, , 823, 8560, , , 8032, , 8078, , 823, 8560, , 8032, 8074, , 8004, , , 8032, , 8078, , 823, 8560, 8980
6 R 2 Squamous cell carcinoma with variants of oral cavity C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C , , 8032, , 8078, , 823, 8560, Squamous carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C Verrucous carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C Squamous cell carcinoma spindle cell C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C Adenosquamous carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C Papillary squamous cell carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C Squamous cell carcinoma, adenoid C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C Basaloid squamous cell carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C Lymphoepithelial carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C Undifferentiated carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C06.9 R 2 Squamous cell carcinoma with variants of lip C00.0-C , 8032, 8074, , 8032, , 8078, , 8560, Squamous carcinoma C00.0-C EPITHELIAL TUMOURS OF OESOPHAGUS C5 R 2 Squamous cell carcinoma with variants of oesophagus C5 3 Squamous carcinoma C , 8004, , , 8032, , 8078, , , 843, 847, 890, , , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, , , 8032, , 8078, , 8560, Adenosquamous carcinoma C Squamous cell carcinoma spindle cell C5 8004, 8032, 8074, Verrucous carcinoma C Papillary squamous cell carcinoma C5 8052
7 3 Basaloid squamous cell carcinoma C Squamous cell carcinoma, adenoid C R 2 Adenocarcinoma with variants of oesophagus C5 R 2 Salivary gland type tumours of oesophagus C , 843, 847, 890, 820, , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, 855, , 8430, 8550, Mucoepidermoid carcinoma C Adenoid cystic carcinoma C R 2 Undifferentiated carcinoma of oesophagus C EPITHELIAL TUMOURS OF STOMACH C6 2 Adenocarcinoma with variants of stomach C6 3 Adenocarcinoma NOS C , 8004, , , 8032, , 8078, , , 847, 890, , , 824, 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, , , , 847, 890, 820, , 824, 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, Adenocarcinoma intestinal type C Signet ring cell carcinoma C Carcinoma diffuse type C Mucinous adenocarcinoma C Tubular adenocarcinoma C Papillary adenocarcinoma, NOS C6 8050, Adenosquamous carcinoma C6 8560
8 R 2 Squamous cell carcinoma with variants of stomach C6 8004, 8032, , 8078, , Squamous carcinoma C Squamous cell carcinoma spindle cell C6 8004, 8032, 8074, Basaloid carcinoma C Verrucous carcinoma C Squamous cell carcinoma, adenoid C Papillary squamous cell carcinoma C R 2 Salivary gland-type tumours of stomach C6 8200, Mucoepidermoid carcinoma C Adenoid cystic carcinoma C R 2 Undifferentiated carcinoma of stomach C EPITHELIAL TUMOURS OF SMALL INTESTINE C7 R 2 Adenocarcinoma with variants of small intestine C7 3 Adenocarcinoma NOS C , 8004, , , 8032, , 8078, , , 843, 847, 890, 820, , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, , , , 843, 847, 890, 820, , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, Mucinous adenocarcinoma C Signet ring cell carcinoma C Adenosquamous carcinoma C Medullary carcinoma, NOS C7 850
9 3 Undifferentiated carcinoma C R 2 Squamous cell carcinoma with variants of small intestine C7 8004, 8032, , 8078, , Squamous carcinoma C EPITHELIAL TUMOURS OF COLON C8, C9 2 Adenocarcinoma with variants of colon C8, C , 8004, , , 8032, , 8078, , , 843, 847, 890, 820, , , , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, , , , 843, 847, 890, 820, , , , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, 8430, , 8450, (only in C8.0, 82-89, C9), 8482, 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, Adenocarcinoma NOS C8, C Mucinous adenocarcinoma C8.0, , C9 (NOT in C8.) 8480/ Signet ring cell carcinoma C8, C Adenosquamous carcinoma C8, C Undifferentiated carcinoma C8, C Medullary carcinoma, NOS C8, C9 850 R 2 Squamous cell carcinoma with variants of colon C8, C9 8004, 8032, , 8078, , Fibromixoma and low grade mucinous C8. adenocarcinoma (pseudomixoma peritonei) of the appendix EPITHELIAL TUMOURS OF RECTUM C20 2 Adenocarcinoma with variants of rectum C , 8004, , , 8032, , 8078, , , , 843, 847, 890, 820, , , , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, , , , 843, 847, 890, 820, , , , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562,
10 3 Adenocarcinoma NOS C Mucinous adenocarcinoma C Signet ring cell carcinoma C Adenosquamous carcinoma C Undifferentiated carcinoma C Medullary carcinoma, NOS C R 2 Squamous cell carcinoma with variants of rectum C , 8032, , 8078, , , Verrucous carcinoma C Basaloid carcinoma of rectum C Basaloid carcinoma of rectum C EPITHELIAL TUMOURS OF ANAL CANAL C2 R 2 Squamous cell carcinoma with variants of anal canal C2 3 Verrucous carcinoma C , 8004, , , 8032, , 8078, , , , 843, 847, 890, 820, , 825, 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, , , , 8032, , 8078, , 8980, Undifferentiated carcinoma C Basaloid carcinoma of anal canal C R 2 Adenocarcinoma with variants of anal canal C2 3 Mucinous adenocarcinoma C , 843, 847, 890, 820, , 825, 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 840, 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, , 8560, 8562, R 2 Paget's disease of anal canal C2 8542
11 EPITHELIAL TUMOURS OF PANCREAS C25 2 Adenocarcinoma with variants of pancreas C25 3 Adenocarcinoma NOS C , 8004, , , 8032, 8035, , 8078, , , 843, 847, 890, 820, , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , 8450, , 8470, , 8490, 8500, , 850, 852, , 8542, , 8560, 8562, , , , , 843, 847, 890, 820, , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, 8440, 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, 855, 8560, 8562, Mucinous adenocarcinoma C Undifferentiated carcinoma C Signet ring cell carcinoma C Adenosquamous carcinoma C R 2 Squamous cell carcinoma with variants of pancreas C , 8032, , 8078, , 8980 R 2 Acinar cell carcinoma of pancreas C R 2 Mucinous cystadenocarcinoma of pancreas C R 2 Intraductal papillary mucinous carcinoma invasive of pancreas C R 2 Solid pseudopapillary carcinoma of pancreas C R 2 Serous cystadenocarcinoma of pancreas C R 2 Carcinoma with osteoclast-like giant cells of pancreas C EPITHELIAL TUMOURS OF LIVER AND INTRAEPATIC BILE TRACT (IBT) C , 8004, , , 8032, , 8078, , , 843, 847, , , 880, 890, 820, , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, , 8980 R 2 Hepatocellular carcinoma of Liver and IBT C22 870, , 880
12 3 Combined hepatocellular carcinoma and cholangiocarcinoma C Hepatocellular carcinoma, fibrolamellar C22 87 R 2 Hepatocellular carcinoma, fibrolamellar C22 87 R 2 Cholangiocarcinoma of IBT C R 2 Adenocarcinoma with variants of liver and IBT C22 R 2 Undifferentiated carcinoma of liver and IBT C , 843, 847, 862, 890, 820, , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, R 2 Squamous cell carcinoma with variants of liver and IBT C , 8032, , 8078, , Bile duct cystadenocarcinoma of IBT C22 86 EPITHELIAL TUMOURS OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT (EBT) R 2 Adenocarcinoma with variants of gallbladder and EBT C23, C24 C , 8004, , , 8032, , 8078, , , 843, 844, 847, , 890, 820, , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, , , 8050, , 843, 844, 847, , 890, 820, , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, Cholangiocarcinoma C Papillary adenocarcinoma, NOS C , Adenocarcinoma intestinal type C Mucinous adenocarcinoma C Clear cell adenocarcinoma, NOS C Signet ring cell carcinoma C
13 3 Adenosquamous carcinoma C Undifferentiated carcinoma C Bile duct cystadenocarcinoma C23 86 R 2 Adenocarcinoma with variants of gallbladder and EBT C23, C , 8050, , 843, 844, 847, , 890, 820, , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , 8450, , 8490, 8500, , 850, 852, 854, 8525, 8542, , 8560, 8562, Cholangiocarcinoma C23, C Papillary adenocarcinoma, NOS C23, C , Adenocarcinoma intestinal type C23, C Mucinous adenocarcinoma C23, C Clear cell adenocarcinoma, NOS C23, C Signet ring cell carcinoma C23, C Adenosquamous carcinoma C23, C Undifferentiated carcinoma C23, C Bile duct cystadenocarcinoma C23, C24 86 R 2 Squamous cell carcinoma of gallbladder and EBT C23, C , 8032, , 8078, , 8980 EPITHELIAL TUMOUR OF TRACHEA C33 R 2 Squamous cell carcinoma with variants of trachea C , 8004, , 8044, , , , 8078, , , , 847, 890, , , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , 8470, , 8490, 8504, 850, 852, 854, 8525, 8542, , 8560, , 8980, , , , , 8078, , 8560, Squamous carcinoma C
14 3 Papillary squamous cell carcinoma C Basaloid squamous cell carcinoma C Squamous cell carcinoma clear cell type C Verrucous carcinoma C Squamous cell carcinoma, adenoid C Spindle cell carcinoma C , 8032, 8074, Adenosquamous carcinoma C Lymphoepithelial carcinoma C Giant cell carcinoma C Undifferentiated carcinoma C R 2 Adenocarcinoma with variants of trachea C33 3 Adenocarcinoma NOS C , 843, 844, 847, 890, 820, , 822, 8230, 823, 8255, , 8290, 830, 835, 8320, 8323, 8333, , , 8470, , 8490, 8504, 850, 852, 854, 8525, 8542, , Mucinous adenocarcinoma C Papillary adenocarcinoma, NOS C Solid carcinoma, NOS C Clear cell adenocarcinoma, NOS C Acinar cell adenocarcinoma C Signet ring cell carcinoma C Mucinous cystadenocarcinoma, NOS C
15 R 2 Salivary gland type tumours of trachea C , 8430, Adenoid cystic carcinoma C Mucoepidermoid carcinoma C Myoepithelial carcinoma C EPITHELIAL TUMOUR OF LUNG C , 8004, , , 8032, 8034, , , 823, , 843, 844, 847, 890, , , 822, 8230, 823, ,- 8246, , , 8290, 830, 835, 8320, 8323, 8333, , 8430, , 8460, 8470, , 8490, 8504, 850, 852, 854, 8525, 8542, , 8560, , 8972, 8980, Squamous cell carcinoma with variants of lung C , 8073, Squamous carcinoma C Papillary squamous cell carcinoma C Basaloid squamous cell carcinoma C Squamous cell carcinoma small cell nonkeratinizing C Squamous cell carcinoma clear cell type C Adenocarcinoma with variants of lung C34 3 Adenocarcinoma NOS C , 843, 844, 847, 890, 820, , 822, 8230, 823, 8255, , 8290, 830, 835, 8320, 8323, 8333, , , 8460, 8470, , 8490, 8504, 850, 852, 854, 8525, 8542, , 8560, Mucinous adenocarcinoma C Papillary adenocarcinoma, NOS C Solid carcinoma, NOS C Clear cell adenocarcinoma, NOS C34 830
16 3 Acinar cell adenocarcinoma C Signet ring cell carcinoma C Adenosquamous carcinoma C Mucinous cystadenocarcinoma, NOS C Adenocarcinoma with mixed subtypes C Fetal adenocarcinoma C R 2 Large cell carcinoma of lung C34 802, 8034, , 823 R 2 Atypical carcinoid of lung C , Poorly differentiated endocrine carcinoma of lung C34 803, , Small cell endocrine carcinoma of the lung C Large cell endocrine carcinoma of the lung C R 2 Bronchiolo-alveolar carcinoma of lung C Bronchiolo-alveolar carcinoma, mucinous C Bronchiolo-alveolar carcinoma, non mucinous C Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous C R 2 Salivary gland type tumours of lung C , 8430, Adenoid cystic carcinoma C Mucoepidermoid carcinoma C Myoepithelial carcinoma C R 2 Sarcomatoid carcinoma of lung C , 8022, , 8074, 8980, 8972
17 3 Sarcomatoid carcinoma C Pleomorphic carcinoma C Giant cell carcinoma C Carcinosarcoma, NOS C Spindle cell carcinoma C , 8032, Pulmonary blastoma C R 2 Undifferentiated carcinoma of lung C EPITHELIAL TUMOURS OF THYMUS C37 R 2 Malignant thymoma C , , , 8032, , 8078, , 823, , , 847, 890, , , 822, , 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , , 8490, 8504, 850, 852, 854, 8525, 8542, , 8560, , Thymoma, malignant, NOS C Malignant thymoma, type AB C Malignant thymoma, type A C Malignant thymoma, type B C , 8584, Malignant thymoma, type C C R 2 Squamous cell carcinoma of thymus C , 8078, , 823 R 2 Undifferentiated carcinoma of thymus C R 2 Lymphoepithelial carcinoma of thymus C R 2 Adenocarcinoma with variants of thymus C , , 843, 844, 847, 890, , , 822, 8230, 823, 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , , 8490, 8504, 850, 852, 854, 8525, 8542, , 8560,
18 3 Adenocarcinoma NOS C Papillary adenocarcinoma, NOS C , 8260 EPITHELIAL TUMOURS OF BREAST C50 2 Invasive ductal carcinoma of breast C , , 8022, 8070, , 843, 847, 890, , , 822, , 8255, , 8290, 830, , 8320, 8323, 8333, , 840, 8430, , 8490, , 8508, 850, , , 8530, , 8543, , 8560, 8562, , , 8500, 850, 8503, 854, 852, Invasive lobular carcinoma of breast C ,8520, Classic type C Pleomorphic carcinoma C R 2 Mammary Paget s disease of breast C , 854, 8543 R 2 Special types of adenocarcinoma of breast C50 3 Tubular adenocarcinoma C , 820, 82, 8260, 8290, , 840, , 8502, Mucinous carcinoma C Medullary carcinoma, NOS C Papillary adenocarcinoma, NOS C , Cribriform carcinoma C Apocrine adenocarcinoma C Secretory carcinoma C Glycogen-rich clear cell carcinoma C Lipid-rich carcinoma C Oncocytic carcinoma C
19 R 2 Metaplastic carcinoma of breast C , 8560, 857, 8572, Squamous carcinoma C Adenosquamous carcinoma C Adenocarcinoma with cartilaginous and osseous metaplasia C Adenocarcinoma with spindle cell metaplasia C R 2 Salivary gland type tumours of breast C , 8430, 8550, Mucoepidermoid carcinoma C Adenoid cystic carcinoma C Myoepithelial carcinoma C Acinar cell adenocarcinoma C R 2 Epithelial tumour of male breast C50 EPITHELIAL TUMOURS OF CORPUS UTERI C , , 8022, 8070, , 843, 847, 890, , , 822, , 8255, , 8290, 830, , 8320, 8323, 8333, , 840, 8430, , 8490, , 8508, 850, , , 8530, , 8543, , 8560, 8562, , , 800, 800, 80, , , 820, 822, 823, , 843, 844, 847, 890, 8200, 820, , 822, 8230, 823, 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , , 8490, 8504, 850, 852, 854, 8525, 8542, , 8560, , , 8980, 9000, 90 2 Adenocarcinoma with variants of corpus uteri C54 3 Adenocarcinoma, NOS C54 820, 822, 823, , 843, 844, 847, 890, 820, , 822, 8230, 823, 8255, , 8290, 835, 8320, 8323, 8333, , 8430, 8440, 8460, , 8490, 8504, 850, 852, 854, 8525, 8542, , 8560, , 9000, Endometrioid adenocarcinoma, NOS C Adenosquamous carcinoma C
20 3 Mucinous adenocarcinoma C Mixed cell adenocarcinoma C Endometrioid adenocarcinoma secretory variant C Villous adenocarcinoma C Brenner tumor, malignant Transitional cell carinoma Transitional cell ca spindle cell Basaloid carcinoma Endometrioid adenocarcinoma ciliated cell variant R 2 Squamous cell carcinoma with variants of corpus uteri C54 C , R 2 Adenoid cystic carcinoma of corpus uteri C Clear cell adenocarcinoma, NOS C Serous (papillary) carcinoma C R 2 Mullerian mixed tumour C , 895, Small cell carcinoma NET new morphology. ICD-O code not available EPITHELIAL TUMOURS OF CERVIX UTERI C53 R 2 Squamous cell carcinoma with variants of cervix uteri C53 3 Squamous carcinoma C , 800, 800, 80, 805, , 8032, , 820, 823, , 843, 844, 847, 890, , , 822, 8230, 823, 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , , 8490, 8504, 850, 852, 854, 8525, 8542, , 8560, , , 8980, , 820, 823,
21 3 Squamous cell carcinoma nonkeratinizing, NOS C Squamous cell carcinoma keratinizing, NOS C Papillary squamous cell carcinoma C Papillary carcinoma, NOS C Verrucous/Warty carcinoma C Basaloid carcinoma C Squamous cell carcinoma spindle cell C Lymphoepithelial carcinoma C Transitional cell carcinoma, NOS C Glassy cell carcinoma C R 2 Adenocarcinoma with variants of cervix uteri C53 3 Adenocarcinoma, NOS C , 843, 844, 847, 890, , , 822, 8230, 823, 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , 8460, , 8490, 8504, 850, 852, 854, 8525, 8542, , , Adenocarcinoma with squamous metaplasia C Mucinous adenocarcinoma C Clear cell adenocarcinoma, NOS C Endometrioid adenocarcinoma, NOS C Serous cystadenocarcinoma, NOS C Signet ring cell carcinoma C Mesonephroma malignant C53 90
22 3 Villous adenocarcinoma C Mucinous adenocarcinoma, endocervical type C Adenocarcinoma intestinal type C Mixed cell adenocarcinoma C R 2 Undifferentiated carcinoma of cervix uteri C R 2 Mullerian mixed tumour of cervix uteri C , 895, Small cell carcinoma NET new morphology. ICD-O code not available MIXED EPITHELIAL AND MESENCHYMAL TUMOURS OF UTERUS C53.0-C , , Mullerian mixed tumour C53.0-C , Adenosarcoma C53.0-C EPITHELIAL TUMOURS OF OVARY AND FALLOPIAN TUBE C56.9, C57.0-C , 800, 800, 80, 8050, 820, 822, 823, , 843, 847, 890, , , 822, 8230, 823, 8255, , 8290, 833, 833, 835, 8320, 8323, 8333, , 8430, , , 8504, 850, 852, 854, 8525, 8542, , 8560, , , 8980, 9000, , 90 (and 8050, 8260, 844, 8450, 8460, 846 in C48) R 2 Adenocarcinoma with variants of ovary C Serous (papillary) cystadenocarcinoma C , 820, 822, 823, , 843, 847, 890, , , 823, 8255, , 8290, 833, 835, 8320, 822, 8230, 8323, 8333, , 8430, , 8504, 850, 852, 854, 8525, 8542, , 8560, , 9000, , , 8460, Adenocarcinoma NOS C Endometrioid adenocarcinoma, NOS C Papillary adenocarcinoma, NOS C , 8260, Endometrioid adenofibroma malignant C
23 3 Clear cell adenocarcinofibroma C Serous adenocarcinofibroma C Mucinous adenocarcinofibroma C Brenner tumor, malignant C Transitionalcell carinoma C Transitional cell ca spindle cell C Basoloid carcinoma C R 2 Mucinous adenocarcinoma of ovary C R 2 Clear cell adenocarcinoma of ovary C Primary peritoneal serous/papillary carcinoma C , 8260, 844, 8450, 8460, 846 R 2 Mullerian mixed tumour of ovary C , 895, Small cell NET new morphology. ICD-O code not available R 2 Adenocarcinoma with variants of fallopian tube C57.0-C Adenocarcinoma NOS C57.0-C , , 843, 847, 890, , , 822, 8230, 823, 8255, , 8290, 830, 835, 8320, 8323, 8333, , 8430, , 8460, , 8490, 8504, 850, 852, 854, 8525, 8542, , 8560, , , Papillary serous cystadenocarcinoma C57.0-C Serous cystadenocarcinoma, NOS C57.0-C Papillary adenocarcinoma, NOS C57.0-C , 8260 NON EPITHELIAL TUMOURS OF OVARY C , 8620, , 8634, 8640, 8650, 8670, 8933, , 8980, , , , 9090, , 939, 9440, 9473, 950
24 R 2 Mixed epithelial/mesenchymal tumours of ovary 3 Mullerian mixed tumour (become tier 2 of epithelial tumors of ovary) C56 C , , , Adenosarcoma C R 2 Sex cord tumours of ovary C , 8620, , 8634, 8640, 8650, Granulosa cell tumour malignant C /3 3 Granulosa cell tumour malignant, adult type C56 3 Granulosa cell tumour malignant, juvenile type C56 3 Sertoli-Leydig cell tumour poorly differentiated C / this is included in the list however it will not be included in the analyses because/ 8622/ this is included in the list however it will not be included in the analyses because/ Steroid cell tumour, malignant C R 2 Malignant/Immature teratomas of ovary C , 9090, 902, 939, 9440, 9473, Teratoma, malignant, NOS C Struma ovarii, malignant C Primitive neuroectodermal tumour, NOS C Ependymoma C Medulloepithelioma, NOS C Glioblastoma C R 2 Germ cell tumour of ovary C , , 9085, Dysgerminoma/Seminoma C Yolk sac tumour C56 907
25 3 Mixed germ cell tumour C Embryonal adenocarcinoma C Choriocarcinoma, NOS C Polyembryoma C EPITHELIAL TUMOURS OF VULVA AND VAGINA C5, C52 R 2 Squamous cell carcinoma with variants of vulva and vagina C5, C , 800, 800, 80, , , , 843, 847, , , , 8290, 830, 835, 8320, 8323, 8333, , , 8430, , 8500, , 850, 852, 854, 8525, 8542, , 8560, R 2 Adenocarcinoma with variants of vulva and vagina C5, C , 843, 847, , , , 8290, 830, 835, 8320, 8323, 8333, , , 8430, , 8500, , 850, 852, 854, 8525, , 8560, R 2 Paget's disease of vulva and vagina C5, C R 2 Undifferentiated carcinoma of vulva and vagina C5, C TROPHOBLASTIC TUMOUR OF PLACENTA C , 905 R 2 Choriocarcinoma of placenta C EPITHELIAL TUMOURS OF PROSTATE C6, C637 2 Adenocarcinoma with variants of prostate C6 3 Adenocarcinoma NOS C , , 8032, 8050, , 8074, 8082, 820, , , , 843, 847, 890, , , , 8360, 8255, , 8290, 830, 8320, 8323, 8333, ,8430, 8440, , 8500, , 850, 852, 854, 8525, 8542, , 8560, , 8074, 8082, , 843, 890, , 823, 8255, , 8290, 830, 8320, 8323, 8333, ,8430, 8440, , 8504, 850, 852, 854, 8525, 8542, , Acinar cell adenocarcinoma C Mucinous adenocarcinoma C Signet ring cell carcinoma C6 8490
26 3 Adenocarcinoma with neuroendocrine differentiation C Oxyphilic adenocarcinoma C Spindle cell adenocarcinoma C6 8032, 8074, Lymphoepithelial carcinoma C R 2 Squamous cell carcinoma with variants of prostate C , 8560, Squamous carcinoma C Adenosquamous carcinoma C Basaloid carcinoma C6 823 R 2 Infiltrating duct carcinoma of prostate C6 8050, 820, 8230, 8260, 8500, Cribriform carcinoma C Solid carcinoma, NOS C Papillary adenocarcinoma, NOS C6 8050, 8260 R 2 Transitional cell carcinoma of prostate C6 820, 822, R 2 Salivary gland type tumours of prostate C6 823, 847 and Adenoid cystic carcinoma C Basal cell adenocarcinoma C6 847 TESTICULAR AND PARATESTICULAR CANCERS C62, C63.0, C63., C63.8 R 2 Paratesticular adenocarcinoma with variants C63.0, C , 800,800,80, 820, 823, , 847, 890, , 822, 823, 8255, 8260, , 8290, 830, 8320, 8323, 8333, , 840, 8430, , 8470, , 8504, 850, 852, 854, 8525, 8542, , 8560, , 8590, , 8650, 8670, , 823, , 847, 890, 8200, , 822, 8230, 823, 8255, 8260, , 8290, 830, 8320, 8323, 8333, , 840, 8430, , 8470, , 8504, 850, 852, 854, 8525, 8542, , 8560,
27 3 Endometrioid adenocarcinoma, NOS C63.0, C Clear cell adenocarcinoma, NOS C63.0, C Serous cystadenocarcinoma, NOS C63.0, C Mucinous cystadenocarcinoma, NOS C63.0, C Collecting duct and rete testis carcinoma C63.0, C63. malignancy without ICD-O morphology code 3 Transitional cell carcinoma, NOS C63.0, C R 2 Non seminomatous testicular cancer C , 9085, , 9065, Mixed germ cell tumour C Teratocarcinoma C Choriocarcinoma combined with other germ cell elements C Embryonal adenocarcinoma, NOS C Yolk sac tumour C Choriocarcinoma, NOS C R 2 Seminomatous testicular cancer C Seminoma, NOS C R 2 Spermatocytic seminoma C R 2 Teratoma with malignant transformation C R 2 Testicular sex cord cancer C , 8650, Leydig cell tumour malignant C Sertoli cell carcinoma C
28 3 Malignant sex cord/gonadal stromal tumours C borderline malignancy EPITHELIAL TUMOURS OF PENIS C60 R 2 Squamous cell carcinoma with variants of penis C , , , , 8090, 8094, , 823, 830, 840, 847, 890, , , 822, , , 8290, 830, 8320, 8323, 8333, 840, , ,8504, 850, 852, 854, 8525, 8542, , , , , Squamous carcinoma C Adenosquamous carcinoma C Verrocous carcinoma C Squamous cell carcinoma, sarcomatoid C Basaloid carcinoma C R 2 Adenocarcinoma with variants of penis C60 3 Extramammary Paget's disease C , 847, 890, , , , , 830, 8323, 8440, , 8504, 850, 852, 854, 8525, 8542, , Sebaceous adenocarcinoma C Papillary adenocarcinoma, NOS C Mixed tumour malignant, NOS C Clear cell adenocarcinoma, NOS C Basal cell adenocarcinoma C EPITELIAL TUMOURS OF KIDNEY C64 2 Renal cell carcinoma with variants C , , 8020, 8022, , , 8090, 8094, 820, 822, 823, , , 843, 847, 890, 8200, 820, , 822, , , 8290, 830, 832, , 8323, 8333, , 840, 8430, 8440, , , , 854, 8525, 8542, , , , , 843, 847, 890, 8200, 820, 82, 822, , , 8290, 830, 832, , 8323, 8333, 840, 8430, 8440, , , , 854, 8525, 8542, , 8562
29 3 Adenocarcinoma NOS C Renal cell adenocarcinoma C Clear cell adenocarcinoma, NOS C Papillary adenocarcinoma, NOS C , Renal cell carcinoma chromophobe type C Collecting duct carcinoma C Xp translocation carcinoma C64 malignancy without ICD-O morphology code 3 Carcinoma associated with neuroblastoma C64 malignancy without ICD-O morphology code 3 Renal medullary carcinoma C Mucinous tubular and spindle cell carcinoma C64 malignancy without ICD-O morphology code R 2 Squamous cell carcinoma spindle cell type of kidney R 2 Squamous cell carcinoma with variants of kidney EPITHELIAL TUMOURS OF PELVIS AND URETER AND URETHRA C64 C64 C65.9,C66.9,C , 8074, , , , , , 8020, 8022, 803, , 8090, 8094, 820, 822, 823, , , 843, 847, 890, 8200, 820, , 822, , , 8290, 830, 8320, 8323, 8333, 840, , , 8504, 850, 852, 854, 8525, 8542, , R 2 Transitional cell carcinoma of pelvis and ureter and urethra C65.9,C66.9,C , 803, , 820, 822, Undifferentiated carcinoma C65.9,C66.9,C Transitional cell carcinoma spindle cell C65.9,C66.9,C Lymphoepithelioma-like carcinoma C65.9,C66.9,C Transitional cell carcinoma, giant cell C65.9,C66.9,C
30 3 Transitional cell carcinoma, micropapillary C65.9,C66.9,C R 2 Squamous cell carcinoma with variants of pelvis and ureter and urethra C65.9,C66.9,C ; Basaloid carcinoma C65.9,C66.9,C Verrucous carcinoma C65.9,C66.9,C R 2 Adenocarcinoma with variants of pelvis and ureter and urethra C65.9,C66.9,C Mucinous adenocarcinoma C65.9,C66.9,C , 843, 847, 890, 8200, 820, 82, 822, , 8255, , 8290, 830, 8320, 8323, 8430, , 850, 852, 854, 8525, 8542, 8560, Clear cell adenocarcinoma, NOS C65.9,C66.9,C Signet ring cell carcinoma C65.9,C66.9,C Adenoid cystic carcinoma C65.9,C66.9,C R 2 Salivary gland-type tumours of pelvis, ureter and urethra C65.9,C66.9,C , 8200, Basaloid carcinoma C65.9,C66.9,C Adenoid cystic carcinoma C65.9,C66.9,C Mucoepidermoid carcinoma C EPITHELIAL TUMOURS OF URETHRA C68.0 R 2 Transitional cell carcinoma of urethra C , , 8020, 8022, 803, , 8090, 8094, 820, 822, 823, , , 843, 847, 890, 8200, 820, , 822, , , 8290, 830, 8320, 8323, 8333, 840, 8440, , 8504, 850, 852, 854, 8525, 8542, , , 803, 8050, 8082, 820, 822, Undifferentiated carcinoma C Transitional cell carcinoma spindle cell C Lymphoepithelioma-like carcinoma C
31 3 Transitional cell carcinoma, giant cell C Transitional cell carcinoma, micropapillary C R 2 Squamous cell carcinoma with variants of urethra C ; Basaloid carcinoma C Verrucous carcinoma C R 2 Adenocarcinoma with variants of urethra C Mucinous adenocarcinoma C , 843, 847, 890, , 82, 822, , 8255, , 8290, 830, 8320, 8323, 8430, , 850, 852, 854, 8525, 8542, 8560, Clear cell adenocarcinoma, NOS C Signet ring cell carcinoma C Adenoid cystic carcinoma C EPITHELIAL TUMOURS OF BLADDER C67 2 Transitional cell carcinoma of bladder C , , 8020, 8022, 803, , 8090, 8094, 820, 822, 823, , , 843, 847, 890, 8200, 820, , 822, , , 8290, 830, 8320, 8323, 8333, 840, , , 8504, 850, 852, 854, 8525, 8542, , , 803, 8050, 8082, 820, 822, Undifferentiated carcinoma C Transitional cell carcinoma spindle cell C Transitional cell carcinoma with squamous differentiation C67 malignancy without ICD-O morphology code 3 Lymphoepithelial carcinoma C Giant cell carcinoma C Transitional cell carcinoma micropapillary C67 83 R 2 Squamous cell carcinoma with variants of bladder C ; 823
32 3 Basaloid carcinoma C Verrucous carcinoma C R 2 Adenocarcinoma with variants of bladder C67 3 Mucinous adenocarcinoma C , 843, 847, 890, 820, 82, 822, , 8255, , 8290, 830, 8320, 8323, , 850, 852, 854, 8525, 8542, 8560, Clear cell adenocarcinoma, NOS C Signet ring cell carcinoma C R 2 Salivary gland type tumours of bladder C67 823, 8200, Basaloid carcinoma C Adenoid cystic carcinoma C Mucoepidermoid carcinoma C EPITHELIAL TUMOURS OF EYE AND ADNEXA C69.0, C , , 8020, , 8090, 8094, , 823, 830, , 847, 890, , , 822, , , 8290, 830, 8320, 8323, 8333, 840, , , 8504, 850, 852, 854, 8525, 8542, , R 2 Squamous cell carcinoma with variants of eye and adnexa C69.0, C , , Squamous carcinoma C69.0, C Basal cell carcinoma C69.0, C R 2 Adenocarcinoma with variants of eye and adnexa C69.0, C Adenocarcinoma NOS C69.0, C , 847, 890, 8200, 822, , , 8290, 830, 8320, 8323, 840, , , 850, 852, 854, 8525, 8542, , Adenoid cystic carcinoma C69.0, C Mucoepidermoid carcinoma C69.0, C
33 EPITHELIAL TUMOURS OF MIDDLE EAR C , , 8020, , 8090, 8094, , 823, 830, , 847, 890, , , 822, , , 8290, 830, 8320, 8323, 8333, 840, , , 8504, 850, 852, 854, 8525, 8542, , R 2 Squamous cell carcinoma with variants middle ear C , 8090, 8094, 820, 82, 823, Squamous carcinoma C R 2 Adenocarcinoma with variants of middle ear C30. 3 Adenocarcinoma NOS C , 847, 890, 8200, 822, , , 8290, 830, 8320, 8323, 840, , , 850, 852, 854, 8525, 8542, , Adenoid cystic carcinoma C MALIGNANT MESOTHELIOMA all cancer sites R 2 Mesothelioma of pleura and pericardium C Epithelioid malignant mesothelioma C Sarcomatoid malignant mesothelioma C R 2 Mesothelioma of peritoneum and tunica vaginalis C48, C Epithelioid malignant mesothelioma C48, C Sarcomatoid malignant mesothelioma C48, C MALIGNANT SKIN MELANOMA C Superficial spreading melanoma C Nodular melanoma C Lentigo maligna melanoma C Acral lentiginous melanoma malignant C R MALIGNANT MELANOMA OF MUCOSA C00-C26, C30-C34, C52, C65-C
34 R MALIGNANT MELANOMA OF UVEA C69.3-C EPITHELIAL TUMOURS OF SKIN C44, C , 8032, , , , Basal cell carcinoma of skin C44, C Basal cell carcinoma NOS C44, C , Basosquamous carcinoma C44, C Multifocal superficial basal cell carcinoma C44, C Basal cell carcinoma nodular C44, C Basal cell carcinoma fibroepithelial C44, C Adenoid basal carcinoma C44, C Squamous cell carcinoma with variants of skin C44, C , 8032, , , Squamous carcinoma C44, C Verrucous carcinoma C44, C Spindle cell carcinoma C44, C , Pseudo vascular/ Squamous cell carcinoma adenoid C44, C Adenosquamous carcinoma C44, C R ADNEXAL CARCINOMA OF SKIN C44, C , 8200, 82, , , 8542, Nodular hidradenoma, malignant C44, C Sebaceous adenocarcinoma C44, C Adenoid cystic carcinoma C44, C Paget's disease extramammary C44, C
35 3 Apocrine adenocarcinoma C44, C Mucinous adenocarcinoma C44, C Pilomatrix carcinoma C44, C Eccrine poroma, malignant C44, C Mixed tumour malignant, NOS C44, C Sclerosing sweat duct carcinoma C44, C Malignant eccrine spiradenoma C44, C Tubular adenocarcinoma C44, C Eccrine papillary adenocarcinoma C44, C EMBRYONAL NEOPLASMS all cancers sites, except CNS and ANS and peripheral nerves 8960, , 9490, 9500, R (2) NEUROBLASTOMA AND GANGLIONEUROBLASTOMA R (2) NEPHROBLASTOMA C64.9 all cancers sites, except CNS and ANS and peripheral nerves 9490, R (2) RETINOBLASTOMA C R (2) HEPATOBLASTOMA C R (2) PLEUROPULMONARY BLASTOMA C R (2) PANCREATOBLASTOMA C R OLFACTORY NEUROBLASTOMA C30.0-C , 9522, 9523 EXTRAGONADAL GERM CELL TUMOURS all cancers sites except C56, C58 and C , 907, 908, 9084, 9085, 900,90 R 2 Non seminomatous germ cell tumours all cancer sites except C56, C58, C62, C7-C72, C75., C ,9070, 907, 908, 9084, 9085, 900,90
36 3 Embryonal adenocarcinoma, NOS all cancer sites except C56, C58, C62, C7-C72, C75., C Yolk sac tumour all cancer sites except C56, C58, C62, C7-C72, C75., C Teratocarcinoma all cancer sites except C56, C58, C62, C7-C72, C75., C Teratoma with malignant transformation all cancer sites except C56, C58, C62, C7-C72, C75., C Mixed germ cell tumour all cancer sites except C56, C58, C62, C7-C72, C75., C Choriocarcinoma, NOS all cancer sites except C56, C58, C62, C7-C72, C75., C Choriocarcinoma combined with other germ cell elements all cancer sites except C56, C58, C62, C7-C72, C75., C Seminomatous germ cell tumors all cancer sites except C56, C58, C62, C7-C72, C75., C Dysgerminoma all cancer sites except C56, C58, C62, C7-C72, C75., C Seminoma, NOS all cancer sites except C56, C58, C62, C7-C72, C75., C Seminoma, anaplstic all cancer sites except C56, C58, C62, C7-C72, C75., C Spermatocytic seminoma all cancer sites except C56, C58, C62, C7-C72, C75., C Germ cell tumors of CNS C7-C72, C75., C , 9070, 907, 908, 9084, 9085, 900,90 3 Dysgerminoma C7-C72, C75., C Seminoma, NOS C7-C72, C75., C Seminoma, anaplastic C7-C72, C75., C Spermatocytic seminoma C7-C72, C75., C Embryonal adenocarcinoma, NOS C7-C72, C75., C Yolk sac tumour C7-C72, C75., C Teratocarcinoma C7-C72, C75., C
37 3 Teratoma with malignant transformation C7-C72, C75., C Mixed germ cell tumour C7-C72, C75., C Choriocarcinoma, NOS C7-C72, C75., C Choriocarcinoma combined with other germ cell elements C7-C72, C75., C
38 SOFT TISSUE SARCOMA all cancers sites except C40.0-C , 8940, , , , , , 950, 970, 980, 923, 9240, 925, , 9370, , 9540, , (includes sarcoma of unknown primary sites) R 2 Soft tissue sarcoma of head and neck C00.0-C4.8, C30.0-C32.9, C49.0, C73.9, C75.2, C75.4, C , 892, 892, , 8963, , , , 950, 970, 980, 923, 9240, , 9370, , 9540, , Sarcoma NOS C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Epithelioid sarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Desmoplastic small round cell tumour C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Fibrosarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Fibromyxosarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Infantile fibrosarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Myxoinflammatory fibroblastic sarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Malignant fibrous histiocytoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C DFSP C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Well differentiated liposarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Myxoid liposarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Pleomorphic liposarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Mixed type liposarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Dedifferentiated liposarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C Leiomyosarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C borderline malignancy
incidence rate x 100,000/year
Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European
Rare cancers are those with an incidence rate 6/100,000
Rare cancers are those with an incidence rate 6/100,000 Layer Tumour Rate x 100,000 Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.44 3,594 2 Squamous cell carcinoma and variants of the
Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES Squamous cell carcinoma and variants of the Nasal Cavity
Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.471 3060 2 Squamous cell carcinoma and variants of the Nasal Cavity and Sinuses 0.37 2615 3 Squamous carcinoma 0.24 1708
ANNUAL CANCER REGISTRY REPORT-2015
CANCER STATISTICS Distribution of neoplasms ANNUAL CANCER REGISTRY REPORT-2015 Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Hina Asif, Adna Atif, Farhana Badar Of a total of 5,924 new neoplasms diagnosed
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind
Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific /N 8551/3 Acinar adenocarcinoma (C34. _) Lung primaries diagnosed prior to 1/1/2018 use code 8550/3 For prostate (all years) see 8140/3
2018 ICD-O-3 Updates in Table Format with Annotation for Reference
Status Histology Description (this may be preferred term or a synonym) Report Comments New term 8010 3 Urachal carcinoma (C65.9, C66.9, C67._, C68._) New term 8013 3 Combined large cell neuroendocrine
Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific Status /N 8010/3 Urachal carcinoma (C65.9, C66.9, C67. _, C68._) 8013/3 Combined large cell neuroendocrine carcinoma (C34. _, C37.9)
ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN
ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Lubna Nadeem,
2 Berkeley Street, Suite 403, Toronto, Ontario M5A 2W3 Visit us at: Tel: Fax:
E-Path A.I. Engine Knowledge Base Enhancements Version 1.0.0.29 April 1, 2018 The major enhancements in the E-Path Knowledge Base from versions 1.0.0.28 through 1.0.0.29 are as follows: 1. Addition/modification
Other Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1
MPH s 11/8/07 Other s 1 Table 2 Continued Use this two-page table to select combination histology codes. Compare the terms in the diagnosis to the terms in Columns 1 and 2. If the terms match, code the
SHN-1 Human Digestive Panel Test results
SHN-1 Human Digestive Panel Test results HN-30 tongue HN-24 salivary gland HN-12 larynx HN-28 esophagus HN-29 stomach HN-20 pancreas HN-13 liver HN-14 gall bladder HN-27-1 duodenum HN-27-2 ileum HN-27-3
ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN
ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Mehwish Waseem,
CANCER REGISTRY 2002
2 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN 974-7980-57-6 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office
CANCER REGISTRY 2004
2 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN 974-7980-57-6 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office
Methoden / Methods inc. ICCC-3 105
Methoden / Methods inc. ICCC-3 105 Internationale Klassifikation der Krebserkrankungen bei Kindern (ICCC-3) Zuordnung von ICD-O-3-Codes für Morphologie und Topographie zu diagnostischen Kategorien International
RARECARENet country report Bulgaria
RARECARENet country report Bulgaria 26 April 2016 Contents 1. Introduction... 3 2. The epidemiology of rare cancers in Bulgaria... 4 3. Quality indicators for centres of expertise for rare cancers... 5
Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence
Rare Breast Tumours 1. Breast Tumours 1.1 General Results Table 1. Epithelial Tumours of Breast: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival Females EAPC Relative survival
Appendix 4: WHO Classification of Tumours of the pancreas 17
S3.01 The WHO histological tumour type must be recorded. CS3.01a The histological type of the tumour should be recorded based on the current WHO classification 17 (refer to Appendices 4-7). Appendix 4:
CODING TUMOUR MORPHOLOGY. Otto Visser
CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show
S2199 S2200. * Speaker's diagnosis 78
98 21 2 14 13:30 * Speaker's diagnosis 78 S2199 Meningioma 48 Papillary meningioma * 30 Angiomatous meningioma 15 Ependymoma 12 Papillary ependymoma 6 Anaplastic ependymoma 2 Cellular ependymoma 1 Hemangioblastoma
2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING
2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING Eight Groups are Revised for 2018 Head & Neck Colon (includes rectosigmoid and rectum for cases diagnosed 1/1/2018 forward) Lung (2018 Draft not yet
Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact
Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact Dermatitis Psoriasis Lichen Simplex Chronicus Foreign Body
Cancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
Chapter 4. Histological groups
Chapter 4. Histological groups D.M. Parkin, J. Ferlay, K. Shanmugaratnam, L. Sobin, L. Teppo and S.L. Whelan In this volume, the main axis of classification is provided by the predominantly site-based
Cancer Association of South Africa (CANSA)
Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)
2007 Multiple Primary and
2007 Multiple Primary and Histology Coding Rules Beyond the Basics Florida Cancer Data System Annual Conference Tampa, FL July 26,2007 Steven Peace, CTR Westat Carol Johnson, CTR NCI SEER Peggy Adamo,
SUPPLEMENTARY INFORMATION
Supplementary Table 1 trials currently open for patients with pheochromocytoma and/or paraganglima (from trials.gov) www.clinicaltrials.gov; Active PPGL trials Status Of Sunitinib In Patients With Recurrent
Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
bs_bs_banner doi:10.1111/jog.12596 J. Obstet. Gynaecol. Res. Vol. 41, No. 2: 167 177, February 2015 Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
Quiz The main functions of the ovaries are a. To produce oocytes b. To produce estrogen c. To produce progesterone d.
1. The main functions of the ovaries are a. To produce oocytes b. To produce estrogen c. To produce progesterone d. All of the above Quiz 1 2. Which part of the broad ligament suspends the ovaries? a.
RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI EPITHELIAL TUMOURS OF CERVIX UTERI
RARE TUMOURS OF THE FEMALE GENITAL SYSTEM 17% OF FEMALE GENITAL SYSTEM TUMOURS ARE RARE 3 093 553 RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI 6 7 % OF RARE TUMOURS OUT OF
2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma
NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Soft Tissue Sarcoma, Neuroendocrine Tumors (NET) and Gastrointestinal Stromal Tumors (GIST) Agenda Updates Soft Tissue Sarcoma Overview CSv2 MP/H
ANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
Pathology of the female genital tract
Pathology of the female genital tract Common illnesses of the female genital tract Before menarche Developmental anomalies Tumors (ovarial teratoma) Amenorrhea Fertile years PCOS, ovarian cysts Endometriosis
Diagnostic IHC in lung and pleura pathology
Diagnostic IHC in lung and pleura pathology Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark WHO 2004 and Web Malignant mesothelioma Epithelioid
DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #
DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #2006-01 CATEGORY: CLARIFICATION SUBJECT: RESCINDMENT - DSQC MEMORANDUM 2002-08 Coding Complex Morphologic Diagnoses (revised 8/02) EFFECTIVE: For Cases
Comprehensive Cancer Cover
Comprehensive Cancer Cover Tech Spec Comprehensive Cancer Cover provides the life insured with cover for the diagnosis and treatment of defined malignant tumours. These tumours must be characterised either
FINALIZED SEER SINQ QUESTIONS
0076 Source 1: WHO Class CNS Tumors pgs: 33 MP/H Rules/Histology--Brain and CNS: What is the histology code for a tumor originating in the cerebellum and extending into the fourth ventricle described as
Differential Diagnosis of Oral Masses. Palatal Lesions
Differential Diagnosis of Oral Masses Palatal Lesions Palatal Masses Periapical Abscess Torus Palatinus Mucocele Lymphoid Hyperplasia Adenomatous Hyperplasia Benign Salivary Neoplasms Malignant Salivary
WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded
3 cell types in the normal ovary
Ovarian tumors 3 cell types in the normal ovary Surface (coelomic epithelium) the origin of the great majority of ovarian tumors (neoplasms) 90% of malignant ovarian tumors Totipotent germ cells Sex cord-stromal
The European Commission s science and knowledge service. Joint Research Centre
The European Commission s science and knowledge service Joint Research Centre Coding Primary Site and Tumour Morphology JRC-ENCR training course Copenhagen, 25 September 2018 Nadya Dimitrova Outline What
WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not
Oncology Centre Research Unit TUMOR REGISTRY
1 Oncology Centre Research Unit TUMOR REGISTRY ANNUAL REPORT 2013 1 Annual Report Prepared by the Staff of the Tumor Registry Research Unit, Oncology Centre King Faisal Specialist Hospital and Research
S Y M P O S I U M P R O G R A M
Dear colleagues, dear friends We would like to cordially welcome you to the 10 th International Arkadi M. Rywlin International Pathology Slide Seminar in Anatomic Pathology to be held in Split, Croatia.
Institute of Pathology First Faculty of Medicine Charles University. Ovary
Ovary Barrett esophagus ph in vagina between 3.8 and 4.5 ph of stomach varies from 1-2 (hydrochloric acid) up to 4-5 BE probably results from upward migration of columnar cells from gastroesophageal junction
RAMATHIBODI CANCER REPORT
RAMATHIBODI CANCER REPORT 2016 Ramathibodi Cancer Registry : A subsidiary of Ramathibodi Comprehensive Cancer Center Faculty of Medicine, Ramathibodi Hospital Mahidol University Table of content INTRODUCTION...III
EPITHELIAL TUMOURS OF OESOPHAGUS RARE EPITHELIAL TUMOURS OF STOMACH EPITHELIAL TUMOURS OF SMALL INTESTINE RARE EPITHELIAL TUMOURS OF COLON
RARE EPITHELIAL TUMOURS OF THE DIGESTIVE SYSTEM 16% OF DIGESTIVE SYSTEM TUMOURS ARE RARE EPITHELIAL TUMOURS 2 262 271 EPITHELIAL TUMOURS OF OESOPHAGUS RARE EPITHELIAL TUMOURS OF STOMACH 81 1 % OF RARE
BMaP-3 Cancer Database. Aggregate Data File
BMaP-3 Cancer Database Aggregate Data File Contents BMaP-3 Cancer Database... 1 Aggregate Data File... 1 Frequency Tables... 2 Institution... 2 Year_First_Contact... 2 Primary_Site... 3 Sex... 3 Race...
CLIC Sargent Eligibility Criteria
1 Eligibility Criteria DOCUMENT GOVERNANCE: Eligibility criteria Produced by J. Hawkins & Grants Team Sponsored by Dara de Burca Version Approval by Executive Team 10 th June 2014 Board of Trustees 3 rd
Supplementary Online Content
Supplementary Online Content Chacón MR, Enrico DH, Burton J, Waisberg FD, Videla VM. Incidence of placebo adverse events in randomized clinical trials of targeted and immunotherapy cancer drugs in the
Tinh hoàn
Tinh hoàn Tinh hoàn Tinh hoàn Tiền liệt tuyến Tiền liệt tuyến Mào tinh hoàn Mào tinh hoàn Túi tinh Túi tinh Túi tinh Túi tinh So-called cystadenoma of seminal vesicle. Gross appearance of granulomatous
Dr Sanjiv Manek Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust
Dr Sanjiv Manek Oxford Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust Ovarian Endometrial Vulvo-vaginal Cervical Illustration-Cellular Pathology. Oxford
2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013
bs_bs_banner doi:10.1111/jog.12360 J. Obstet. Gynaecol. Res. Vol. 40, No. 2: 338 348, February 2014 Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013 Daisuke
Supplementary Information
Rise in Glioblastoma Multiforme incidence in England 1995 2015 suggests an adverse environmental or lifestyle factor Alasdair Philips, Denis L Henshaw, Graham Lamburn, Michael J O Carroll Supplementary
Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER
Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER Table 1.1 gives the total number of cancers diagnosed at five different hospital based cancer registries (HBCRs), over the period of two years from 1st January
Rare Tumours of Male Genital Organs
Rare Tumours of Male Genital Organs 1. Epithelial Tumours of Prostate 1.1 General Results Table 1. Epithelial Tumours of Prostate: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival
Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases
Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Peiguo G. Chu, M.D., Ph.D., Lawrence M. Weiss, M.D. Department of Pathology, City of Hope National Medical Center,
Gynaecological Malignancies
Gynaecological Malignancies Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea Division of Pathology School of Medicine & Health Sciences Overview Genital tract tumors
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
Protocol for the Examination of Lymphadenectomy Specimens From Patients With Malignant Germ Cell and Sex Cord-Stromal Tumors of the Testis
Protocol for the Examination of Specimens From Patients With Malignant Germ Cell and Sex Cord-Stromal Tumors of the Testis Version: Testis 4.0.1.1 Protocol Posting Date: February 2019 Accreditation Requirements
Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005
ChecklistTemplateVersions ChecklistTemplateVersion Ckey OfficialName VisibleText RevisionDate Checklist; Adrenal gland: 16.1000043 Resection Adrenal gland: Checklist; Ampulla of 17.1000043 Vater: Ampullectomy
3 cell types in the normal ovary
Ovarian tumors 3 cell types in the normal ovary Surface (coelomic epithelium) the origin of the great majority of ovarian tumors 90% of malignant ovarian tumors Totipotent germ cells Sex cord-stromal cells
International Agency for Research on Cancer. World Health Organization International Association of Cancer Registries
International Agency for Research on Cancer World Health Organization International Association of Cancer Registries I A R C I A C R CHECK AND CONVERSION PROGRAMS FOR CANCER REGISTRIES (IARC/IACR Tools
Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.
Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and
Radiation Oncology Study Guide
Radiation Oncology Study Guide For the Initial CertificationQualifying (Computer-Based) Examination General and Radiation Oncology This examination is designed to assess your understanding of the entire
Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק
Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק 26.06.09 Lecture outlines WHO histological classification Macro/Micro assessment Early diagnosis Minimal pathology Main subtypes SCC, AdCa, LCLC
Salivary Glands 3/7/2017
Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.
Lesions Mimicking Adenoid Cystic Carcinoma. Diagnostic Problems in Salivary Gland Pathology An Update 5/29/2009
Diagnostic Problems in Salivary Gland Pathology An Update Lesions Mimicking Adenoid Cystic Carcinoma Stacey E. Mills, M.D. W.S. Royster Professor of Pathology Director of Surgical and Cytopathology University
Epithelial Tissue. Functions include: 1. Protection 4. Absorption 2. Secretion 5. Filtration 3. Sensory reception
Tissues There are 4 primary tissue types in the human body: 1. Epithelial (covering/lining) 2. Connective (support) 3. Muscle (movement) 4. Nervous (control) Epithelium Epithelial Tissue Covers the surface
S2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
Table of Contents. Preface xi. Acknowledgments xiii. Part I Overview of the Diagnostic Process 1. 1 Overview of Grading and Staging 3
Table of Contents Preface xi Acknowledgments xiii Part I Overview of the Diagnostic Process 1 1 Overview of Grading and Staging 3 Identification of the process 3 Identification of tumor types 5 Grading
Normal endometrium: A, proliferative. B, secretory.
Normal endometrium: A, proliferative. B, secretory. Nội mạc tử cung Nội mạc tử cung Cyclic changes in endometrium.. Approximate relationship of useful microscopic changes. Arias-Stella reaction in endometrial
Carcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS
Carcinoma mammario: le istologie non frequenti Valentina Guarneri Università di Padova IOV-IRCCS Histological diversity of breast adenocarcinomas Different histological types are defined according to specific
Supplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15.
SUPPLEMENTARY MATERIALS Supplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15.0) Basket preferred term 5q minus
SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl
SEER Advanced Topic 2018 Presentation EOD 2018 and SS2018 Jennifer Ruhl May 25, 2018 Outline General overview of EOD Schemas Basic review of what is needed to collect Primary Tumor, Regional Nodes and
4/17/2015. Case 1. A 37 year old man with a 2.2 cm solitary left thyroid mass.
Case 1 A 37 year old man with a 2.2 cm solitary left thyroid mass. Case 1 Case 1 1 Case 1: Diagnosis? A. Benign B. Atypia of undetermined significance/follicular lesion of undetermined significance C.
List of Available TMAs in the PRN
TMA RPCI_BrainCa01 RPCI_BrCa03 RPCI_BrCa04 RPCI_BrCa05 RPCI_BrCa0 RPCI_BrCa07 RPCI_BrCa08 RPCI_BrCa15 RPCI_BrCa1 RPCI_BrCa17 RPCI_BrCa18 RPCI_BrCa19 RPCI_BrCa20 RPCI_BrCa21 RPCI_BrCa24 RPCI_BrCa25 RPCI_BrCa2
Pathology of Ovarian Tumours. Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh
Pathology of Ovarian Tumours Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh Outline Incidence Risk factors Classification Pathology of tumours Tumour markers Prevention
Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green
Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green Digestive system 1. Teeth Main points: external and internal structure of a tooth, fixation of a tooth
Breast cancer: IHC classification. Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark
Breast cancer: IHC classification Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark http://upload.wikimedia.org/wikipedia/commons/1/1a/breast.svg
New Developments in Immunohistochemistry for Gynecologic Pathology
New Developments in Immunohistochemistry for Gynecologic Pathology Michael T. Deavers, M.D. Professor, Departments of Pathology and Gynecologic Oncology Immunohistochemistry in Gynecologic Pathology Majority
Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies
Web appendix 2: SEARCH STRATEGIES Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies MEDLINE 1. exp epidemiologic studies/
* Speaker's diagnosis
* Speaker's diagnosis Creutzfeldt-Jacob disease(cjd) 5 Prion disease( Creutzfeldt-Jakob disease ) 3 Extrapontine myelinolytis 5 Subacute sclerosing panencephalitis (SSPE) 5 Central pontine myelinolysis
FINALIZED SEER SINQ QUESTIONS April July, 2017
20170040 Source 1: 2016 SEER Manual pgs: 91 Source 2: 2007 MP/H Rules Notes: Lung MP/H Rules/Histology--Lung: What is the histology code for lung cancer case identified pathologically from a metastatic
82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung
82330 CALCIUM; IONIZED ICD-10 Codes that Support Medical Necessity ICD-10 Code Description A15.0 Tuberculosis of lung A15.4 Tuberculosis of intrathoracic lymph nodes A15.5 Tuberculosis of larynx, trachea
Endometrial adenocarcinoma icd 10 code
Endometrial adenocarcinoma icd 10 code Gogamz Menu Cancer of the endometrium, adenocarcinoma ;. (mucous membrane that lines the endometrial cavity). ICD - 10 -CM C54.1 is grouped within. ICD-10 -CM Diagnosis
Tissue: The Living Fabric: Part A
PowerPoint Lecture Slides prepared by Janice Meeking, Mount Royal College C H A P T E R 4 Tissue: The Living Fabric: Part A Tissues Groups of cells similar in structure and function Types of tissues Epithelial
Slide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana
Slide seminar Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana Case 5 A 57-year-old man with a dermal/subcutaneous lesion on the scalp, which was interpreted
Grade Coding Instructions and Tables
Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward DRAFT published April 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth
Epithelial tumors. Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev
Epithelial tumors Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev Epithelial tumors Tumors from the epithelium are the most frequent among tumors. There are 2 group features of these tumors: The presence in most
2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018
1 2018 Grade PEGGY ADAMO, RHIT, CTR ADAMOM@MAIL.NIH.GOV OCTOBER 11, 2018 2 Acknowledgements Donna Hansen, CCR Jennifer Ruhl, NCI SEER Introduction 3 Histologic Type vs. Grade Credit: Dr. Kay Washington
Anatomic Pathology Study Sets Glass Slides
Anatomic Pathology Study Sets Glass Slides California Tumor Tissue Registry 11021 Campus Street, AH335, Loma Linda, Ca 92350 (909) 558-4788; Fax (909) 558-0188 E-Mail: cttr@llu.edu Web Site: www.cttr.org
National Cancer Intelligence Network Rare and less common cancers. Incidence and Mortality in England, 2010 to 2013
National Cancer Intelligence Network Rare and less common cancers Incidence and Mortality in England, 2010 to 2013 About Public Health England Public Health England exists to protect and improve the nation's
Head and Neck Squamous Subtypes
1 Head and Neck Squamous Subtypes Adel K. El-Naggar, M.D., Ph.D. The University of Texas MD Anderson Cancer Center, Houston, Texas HNSCC 5 th -6 th most common cancer 400,000/year 50% mortality Considerable
CHAPTER 4 Specific tumor sites (part 2)
CANCER REGISTRATION HANDBOOK CHAPTER 4 Specific tumor sites (part 2) Contents IV(2)-2 IV(2)-2 IV(2)-3 IV(2)-3 IV(2)-3 IV(2)-3 IV(2)-3 IV(2)-4 IV(2)-4 IV(2)-4 IV(2)-6 IV(2)-7 IV(2)-7 IV(2)-8 IV(2)-8 IV(2)-8
Icd 10 code met renal cell
Icd 10 code met renal cell Search 1-10-2015 Free, official coding info for 2018 ICD - 10 -CM N16 - includes detailed rules, notes, synonyms, ICD -9-CM conversion, index and annotation crosswalks, DRG.
Recently, there has been an increasing incidence among women and younger persons
Bladder Tumors Benign Transitional Cell Papilloma 2-3% Inverted Papilloma Rare Malignant Transitional (Urothelial) Carcinoma 90% Carcinoma In-Situ (By Itself) 5-10% Squamous Cell Carcinoma 3-7% Adenocarcinoma